CELLFE
LIVE

Serial Number

88844359

Owner

CELLFE, INC.

Attorney

Vladimir Y. Gusev

First Use Date

Aug 9, 2021

Filing Date

Mar 23, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CELLFE Trademark

Serial Number: 88844359 • Registration: 6591175

CELLFE is a trademark filed by CELLFE, INC. on March 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

CELLFE, INC. (3 trademarks)

Alameda, CA 94501

Entity Type: 03

Trademark Details

Filing Date

March 23, 2020

Registration Date

December 14, 2021

First Use Anywhere

August 9, 2021

First Use in Commerce

August 9, 2021

Published for Opposition

January 19, 2021

Goods & Services

Laboratory apparatus in the nature of microfluidic chips for scientific research for use in the delivery of macromolecules, nanoparticles, or polymers to cells; Laboratory apparatus kits comprising microfluidic chips and a pressurized gas system comprised of flow control instruments, gas supply, flow channels, and containers, vessels for scientific research; Laboratory apparatus kits comprising microfluidic chips and pumping systems comprised of flow control instruments, flow pumps, flow channels, and containers, vessels for scientific research

Therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for use in the treatment of medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, and autoimmune diseases; Therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for the prevention of medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, and autoimmune diseases; Living cells for treating medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, autoimmune diseases; Living cells for medical purposes, namely, for creating cell therapies

Medical apparatus in the nature of microfluidic chips for use in cell therapy and immunotherapy for use in the delivery of macromolecules, nanoparticles and polymers to cells; Medical apparatus in the nature of a kit comprising microfluidic chips, a control apparatus, and a pressurized gas system comprised of flow control instruments, gas supply, flow channels, and containers, vessels for delivery of cell therapy, immunotherapy, medical treatments, and diagnostics; Medical equipment in the nature of a kit comprising microfluidic chips, a control apparatus, and a pumping system comprised of flow control instruments, flow pumps, flow channels, and containers, vessels for delivery of cell therapy, immunotherapy, medical treatments, and diagnostics; Medical instruments in the nature of a medical kit comprising disposable microfluidic chips, disposable tubing and disposable containers for medical purposes, namely, generating cells to treat cancer, blood diseases, infectious diseases, autoimmune diseases all for use in cell therapy and immunotherapy medical treatments

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 31, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 31, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 31, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
Dec 14, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 10, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 9, 2021 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 22, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 21, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 21, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 16, 2021 GNRN
NON-FINAL ACTION E-MAILED
Oct 16, 2021 GNRT
SU - NON-FINAL ACTION - WRITTEN
Oct 16, 2021 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Sep 27, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 27, 2021 AITU
USE AMENDMENT FILED
Sep 15, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 15, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 16, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 19, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 19, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 30, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 16, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 16, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 16, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 16, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 16, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 5, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 4, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 15, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 15, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 15, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 14, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2020 NWOS
NEW APPLICATION ENTERED
Mar 26, 2020 NWAP